{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T14:14:15Z","timestamp":1794320055334,"version":"4.9.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,6,20]],"date-time":"2013-06-20T00:00:00Z","timestamp":1371686400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Altern Med"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Growing evidence shows that herb medicines have some anti-osteoporotic effects, the mechanism underlying is unknown. This study aims to investigate the therapeutic effect of Chinese herb supplements on rats that had osteoporosis-like symptom induced by ovariectomy (OVX).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>OVX or sham operations were performed on virgin Wistar rats at three-month old, which were randomly divided into eight groups: sham (sham); OVX control group (OVX); OVX rats with treatments [either diethylstilbestrol (DES) or <jats:italic>Semen Astragali Complanati<\/jats:italic> decoction (SACD) or <jats:italic>Rhizoma Cibotii<\/jats:italic> decoction (RCD) or <jats:italic>Herba Cistanches<\/jats:italic> decoction (HCD) or <jats:italic>Semen Allii Tuberosi<\/jats:italic> decoction (SATD)]. Non-surgical rats were served as a normal control (NC). The treatments began 4 weeks after surgery, and lasted for 12 weeks. Bone mass and its turnover were analyzed by histomorphometry. Levels of protein and mRNA of osteoprotegerin (OPG) and receptor activator of nuclear factor <jats:italic>\u03ba<\/jats:italic> B ligand (RANKL) in osteoblasts (OB) and bone marrow stromal cells (bMSC) were evaluated by immunohistochemistry and <jats:italic>in situ<\/jats:italic> hybridization.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Compared to OVX control, TBV% in both SACD and RCD groups was increased significantly, while TRS%, TFS%, MAR, and mAR were decreased remarkably in the SACD group, only TRS% decreased dramatically in the RCD group. No significant changes in bone formation were observed in either HCD or SATD groups. OPG levels in both protein and mRNA were reduced consistantly in OB and bMSC from OVX control rats, in contrast, RANKL levels in both protein and mRNA were increased significantly. These effects were substantially reversed by treatments with either DES or SACD or RCD. No significant changes in both OPG and RANKL expression were observed in OB and bMSC from OVX rats treated with SATD and HCD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our study showed that SACD and RCD increased bone formation by stimulating OPG expression and downregulating RANKL expression in OB and bMSC. This suggests that SACD and RCD may be developed as alternative anti-osteoporotic agents for therapy of postmenopausal osteoporosis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1472-6882-13-141","type":"journal-article","created":{"date-parts":[[2013,6,20]],"date-time":"2013-06-20T04:35:48Z","timestamp":1371702948000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Semen astragali complanati- and rhizoma cibotii-enhanced bone formation in osteoporosis rats"],"prefix":"10.1186","volume":"13","author":[{"given":"Meijie","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary Guishan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peijing","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiazi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingru","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghua","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglin","family":"Zha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dahong","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,6,20]]},"reference":[{"key":"1397_CR1","doi-asserted-by":"crossref","unstructured":"Consensus Development Conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med. 1993, 94: 646-650.","DOI":"10.1016\/0002-9343(93)90218-E"},{"key":"1397_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1210\/er.2006-0029","volume":"28","author":"P Chavassieux","year":"2007","unstructured":"Chavassieux P, Seeman E, Delmas PD: Insights into material and structural basis of bone fragility from diseases associated with fractures: how determinants of the biomechanical properties of bone are compromised by disease. Endocr Rev. 2007, 28: 151-164.","journal-title":"Endocr Rev"},{"key":"1397_CR3","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.molmed.2004.12.004","volume":"11","author":"TJ Martin","year":"2005","unstructured":"Martin TJ, Sims NA: Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol Med. 2005, 11: 76-81. 10.1016\/j.molmed.2004.12.004.","journal-title":"Trends Mol Med"},{"key":"1397_CR4","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0002-9440(10)62269-9","volume":"166","author":"MA Karsdal","year":"2005","unstructured":"Karsdal MA, Henriksen K, Sorensen MG, Gram J, Schaller S, Dziegiel MH, Heegaard AM, Christophersen P, Martin TJ, Christiansen C, Bollerslev J: Acidification of the osteoclastic resorption compartment provides insight into the coupling of bone formation to bone resorption. Am J Pathol. 2005, 166: 467-476. 10.1016\/S0002-9440(10)62269-9.","journal-title":"Am J Pathol"},{"key":"1397_CR5","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1359\/jbmr.070109","volume":"22","author":"MA Karsdal","year":"2007","unstructured":"Karsdal MA, Martin TJ, Bollerslev J, Christiansen C, Henriksen K: Are nonresorbing osteoclasts sources of bone anabolic activity?. J Bone Miner Res. 2007, 22: 487-494. 10.1359\/jbmr.070109.","journal-title":"J Bone Miner Res"},{"key":"1397_CR6","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1210\/en.2005-1293","volume":"147","author":"F Acconcia","year":"2006","unstructured":"Acconcia F, Barnes CJ, Kumar R: Estrogen and tamoxifen induce cytoskeletal remodeling and migration in endometrial cancer cells. Endocrinology. 2006, 147: 1203-1212.","journal-title":"Endocrinology"},{"key":"1397_CR7","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"The Writing Group for the Women\u2019s Health Initiative Investigators","year":"2002","unstructured":"The Writing Group for the Women\u2019s Health Initiative Investigators: Risks and benefits of estrogen plus progestin in healthy postmenopausal Woman. JAMA. 2002, 288: 321-333. 10.1001\/jama.288.3.321.","journal-title":"JAMA"},{"key":"1397_CR8","volume-title":"BMC Complement Altern Med","author":"M Liu","year":"2012","unstructured":"Liu M, Xiao GG, Rong P, Zhang Z, Dong J, Zhao H, Li H, Li Y, Pan J, Liu H, Wang W, Zha Q, Ju D: Long-term therapeutic effects of Radix Dipsaci, Pyrola Herb, and Cynomorium Songaricum on bone metabolism of ovariectomized rats. BMC Complement Altern Med. 2012, Accepted"},{"key":"1397_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1620\/tjem.158.85","volume":"158","author":"M Yasujima","year":"1989","unstructured":"Yasujima M, Abe K, Kanazawa M, Yoshida K, Kohzuki M, Sato M, Takeuchi K, Omata K, Tsunoda K, Kudo K: Effects of antihypertensive drugs on renal function and atrial natriuretic polypeptide in spontaneously hypertensive rats with renal ablation. Tohoku J Exp Med. 1989, 158: 85-94. 10.1620\/tjem.158.85.","journal-title":"Tohoku J Exp Med"},{"key":"1397_CR10","first-page":"44","volume":"66","author":"JE Dunlap","year":"1976","unstructured":"Dunlap JE: Preventing broken appointments. Dent Econ. 1976, 66: 44-5. 47","journal-title":"Dent Econ"},{"key":"1397_CR11","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2334\/josnusd.50.367","volume":"50","author":"JB Tyrovola","year":"2008","unstructured":"Tyrovola JB, Spyropoulos MN, Makou M, Perrea D: Root resorption and the OPG\/RANKL\/RANK system: a mini review. J Oral Sci. 2008, 50: 367-376. 10.2334\/josnusd.50.367.","journal-title":"J Oral Sci"},{"key":"1397_CR12","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1001\/jama.292.4.490","volume":"292","author":"LC Hofbauer","year":"2004","unstructured":"Hofbauer LC, Schoppet M: Clinical implications of the osteoprotegerin\/RANKL\/RANK system for bone and vascular diseases. JAMA. 2004, 292: 490-495. 10.1001\/jama.292.4.490.","journal-title":"JAMA"},{"key":"1397_CR13","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1136\/ard.2009.121764","volume":"69","author":"LH Van Tuyl","year":"2010","unstructured":"Van Tuyl LH, Voskuyl AE, Boers M, Geusens P, Landewe RB, Dijkmans BA, Lems WF: Baseline RANKL:OPG ratio and markers of bone and cartilage degradation predict annual radiological progression over 11 years in rheumatoid arthritis. Ann Rheum Dis. 2010, 69: 1623-1628. 10.1136\/ard.2009.121764.","journal-title":"Ann Rheum Dis"},{"key":"1397_CR14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jep.2009.02.025","volume":"123","author":"ZG Liu","year":"2009","unstructured":"Liu ZG, Zhang R, Li C, Ma X, Liu L, Wang JP, Mei QB: The osteoprotective effect of Radix Dipsaci extract in ovariectomized rats. J Ethnopharmacol. 2009, 123: 74-81. 10.1016\/j.jep.2009.02.025.","journal-title":"J Ethnopharmacol"},{"key":"1397_CR15","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1056\/NEJMra053077","volume":"354","author":"E Seeman","year":"2006","unstructured":"Seeman E, Delmas PD: Bone quality--the material and structural basis of bone strength and fragility. N Engl J Med. 2006, 354: 2250-2261. 10.1056\/NEJMra053077.","journal-title":"N Engl J Med"},{"key":"1397_CR16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1210\/er.2007-0014","volume":"29","author":"AE Kearns","year":"2008","unstructured":"Kearns AE, Khosla S, Kostenuik PJ: Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocr Rev. 2008, 29: 155-192.","journal-title":"Endocr Rev"},{"key":"1397_CR17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0378-1119(97)00509-X","volume":"204","author":"KB Tan","year":"1997","unstructured":"Tan KB, Harrop J, Reddy M, Young P, Terrett J, Emery J, Moore G, Truneh A: Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells. Gene. 1997, 204: 35-46. 10.1016\/S0378-1119(97)00509-X.","journal-title":"Gene"},{"key":"1397_CR18","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/emm.2002.49","volume":"34","author":"KM Woo","year":"2002","unstructured":"Woo KM, Choi Y, Ko SH, Ko JS, Oh KO, Kim KK: Osteoprotegerin is present on the membrane of osteoclasts isolated from mouse long bones. Exp Mol Med. 2002, 34: 347-352. 10.1038\/emm.2002.49.","journal-title":"Exp Mol Med"},{"key":"1397_CR19","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1359\/JBMR.040604","volume":"19","author":"T Kondo","year":"2004","unstructured":"Kondo T, Kitazawa R, Maeda S, Kitazawa S: 1 alpha,25 dihydroxyvitamin D3 rapidly regulates the mouse osteoprotegerin gene through dual pathways. J Bone Miner Res. 2004, 19: 1411-1419. 10.1359\/JBMR.040604.","journal-title":"J Bone Miner Res"},{"key":"1397_CR20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cytogfr.2003.10.005","volume":"15","author":"TS Kwan","year":"2004","unstructured":"Kwan TS, Padrines M, Theoleyre S, Heymann D, Fortun Y: IL-6, RANKL, TNF-alpha\/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev. 2004, 15: 49-60. 10.1016\/j.cytogfr.2003.10.005.","journal-title":"Cytokine Growth Factor Rev"},{"key":"1397_CR21","doi-asserted-by":"publisher","first-page":"5050","DOI":"10.1210\/endo.142.12.8536","volume":"142","author":"S Khosla","year":"2001","unstructured":"Khosla S: Minireview: the OPG\/RANKL\/RANK system. Endocrinology. 2001, 142: 5050-5055. 10.1210\/en.142.12.5050.","journal-title":"Endocrinology"},{"key":"1397_CR22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1055\/s-2001-11050","volume":"126","author":"LC Hofbauer","year":"2001","unstructured":"Hofbauer LC, Heufelder AE: Osteoprotegerin ligand and osteoprotegerin: new concepts of the pathogenesis and therapy of metabolic bone diseases. Dtsch Med Wochenschr. 2001, 126: 145-150. 10.1055\/s-2001-11050.","journal-title":"Dtsch Med Wochenschr"},{"key":"1397_CR23","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1002\/1529-0131(200010)43:10<2143::AID-ANR1>3.0.CO;2-S","volume":"43","author":"EM Gravallese","year":"2000","unstructured":"Gravallese EM, Goldring SR: Cellular mechanisms and the role of cytokines in bone erosions in rheumatoid arthritis. Arthritis Rheum. 2000, 43: 2143-2151. 10.1002\/1529-0131(200010)43:10<2143::AID-ANR1>3.0.CO;2-S.","journal-title":"Arthritis Rheum"},{"key":"1397_CR24","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","volume":"12","author":"N Bucay","year":"1998","unstructured":"Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS: osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 1998, 12: 1260-1268. 10.1101\/gad.12.9.1260.","journal-title":"Genes Dev"},{"key":"1397_CR25","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1083\/jcb.145.3.527","volume":"145","author":"TL Burgess","year":"1999","unstructured":"Burgess TL, Qian Y, Kaufman S, Ring BD, Van G, Capparelli C, Kelley M, Hsu H, Boyle WJ, Dunstan CR, Hu S, Lacey DL: The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. J Cell Biol. 1999, 145: 527-538. 10.1083\/jcb.145.3.527.","journal-title":"J Cell Biol"},{"key":"1397_CR26","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/S8756-3282(98)00141-0","volume":"23","author":"T Akatsu","year":"1998","unstructured":"Akatsu T, Murakami T, Ono K, Nishikawa M, Tsuda E, Mochizuki SI, Fujise N, Higashio K, Motoyoshi K, Yamamoto M, Nagata N: Osteoclastogenesis inhibitory factor exhibits hypocalcemic effects in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancy. Bone. 1998, 23: 495-498. 10.1016\/S8756-3282(98)00141-0.","journal-title":"Bone"}],"container-title":["BMC Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6882-13-141.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-6882-13-141\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6882-13-141","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6882-13-141.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:32:13Z","timestamp":1630542733000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/1472-6882-13-141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,20]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1397"],"URL":"https:\/\/doi.org\/10.1186\/1472-6882-13-141","relation":{},"ISSN":["1472-6882"],"issn-type":[{"value":"1472-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,20]]},"assertion":[{"value":"13 January 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"141"}}